A carregar...
AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
BACKGROUND: The At-rich interactive domain 1A (ARID1A) is frequently mutated in gastric cancers (GCs) with a poor prognosis. Growing evidence indicates that loss of ARID1A expression leads to activation of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway by AKT phosphorylation. We aim to investi...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5574587/ https://ncbi.nlm.nih.gov/pubmed/28860825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S139664 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|